Exton Michael — SEC Form 4 filings

SEC reporting owner CIK 2029249. 4 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-07-08 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LEXICON PHARMACEUTICALS, INC. (LXRX)Chief Executive Officer, Director48

Form 4 filings — Exton Michael

FiledFormIssuerReported transactionsSource
2026-03-034LEXICON PHARMACEUTICALS, INC. (LXRX)Option exercise (M): 503,263 · Tax withholding (F): 204,831 @ $1.47 · Option exercise (M): 503,263 (derivative)EDGAR
2026-02-174LEXICON PHARMACEUTICALS, INC. (LXRX)Grant/award (A): 862,440 (derivative) @ $0 · Grant/award (A): 1,293,670 (derivative) @ $0EDGAR
2025-02-184LEXICON PHARMACEUTICALS, INC. (LXRX)Grant/award (A): 2,264,690 (derivative) @ $0 · Grant/award (A): 1,509,790 (derivative) @ $0EDGAR
2024-07-084LEXICON PHARMACEUTICALS, INC. (LXRX)Grant/award (A): 1,675,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2029249 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →